1211639

Sami Ibrahimi, M.D. — FEI 3027223001

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Oklahoma City, OK (United States)

Additional Details

Clinical Investigator (CI)